Browse Arkansas Code titles and sections
20-16-1505. Reporting.
Arkansas Code — all titles (historical 2020) · legal_authorities
20-16-1505. Reporting.
(a) If a physician provides an abortion-inducing drug to another for the purpose of inducing an abortion as authorized in § 20-16-1504 and if the physician knows that the woman who uses the abortion-inducing drug for the purpose of inducing an abortion experiences an adverse event, the physician shall provide a written report of the adverse event within three (3) days of the event to the United States Food and Drug Administration via the MedWatch program reporting system and to the Arkansas State Medical Board.
(b)(1) The board shall compile and retain all reports it receives under this section.
(2)(A) All reports received by the board are public records open to inspection under the Freedom of Information Act of 1967, § 25-19-101 et seq.
(B) The board shall not release to any person or entity the name or any other personal identifying information regarding a person who:
(i) Uses an abortion-inducing drug to induce an abortion; and
(ii) Is the subject of a report received by the board under this section.
Source: Arkansas Code — historical release 78 (November 6, 2020) · 20-16-1505
Stored review status: Historical 2020-11-06 source release; later amendments not reconciled; machine-extracted, not independently legally reviewed; source heading status: text_in_historical_source. A text match is a research starting point; applicability is not established.
Issuing source page ↗
Authority boundary: historical statutory source snapshot not current law.
Open the recorded source website ↗
Record provenance
Stable record: arkansas_code:legal_authorities:20-16-1505
Source file: gov.ar.code.title.20.odt
Pages: Not recorded – Not recorded
Passage SHA-256: 2119b32a70018d7da65a60ca0135c5f4fd1503aa0c00d06c85e39b12200d913e
Source location: content.xml paragraph 13923
Stored source content
20-16-1505. Reporting.
(a) If a physician provides an abortion-inducing drug to another for the purpose of inducing an abortion as authorized in § 20-16-1504 and if the physician knows that the woman who uses the abortion-inducing drug for the purpose of inducing an abortion experiences an adverse event, the physician shall provide a written report of the adverse event within three (3) days of the event to the United States Food and Drug Administration via the MedWatch program reporting system and to the Arkansas State Medical Board.
(b)(1) The board shall compile and retain all reports it receives under this section.
(2)(A) All reports received by the board are public records open to inspection under the Freedom of Information Act of 1967, § 25-19-101 et seq.
(B) The board shall not release to any person or entity the name or any other personal identifying information regarding a person who:
(i) Uses an abortion-inducing drug to induce an abortion; and
(ii) Is the subject of a report received by the board under this section.
Cross-references
Connections may be documented source relationships, shared citations or nearby passages. Each explains its basis; a connection alone does not establish applicability to your situation.
Arkansas Code — all titles (historical 2020) · legal_authorities
20-16-1504. Unlawful distribution of abortion-inducing drug.
(a)(1) It shall be unlawful to knowingly give, sell, dispense, administer, or otherwise provide or prescribe an abortion-inducing drug to a pregnant woman to induce an abortion or enable another person to induce an abortion unless the person who gives, sells, dispenses, administers, or otherwise provides or prescribes the abortion-inducing drug is a physician and the provision or prescription of the abortion-inducing drug satisfies the protocol authorized by the United States Food and Drug Administration, as outlined in the final printed labeling for the drug or drug regimen.
(2) In the case of the Mifeprex regimen, the final printed labeling for Mifeprex includes the United States Food and Drug Administration-approved dosage and administration instructions for both mifepristone and misoprostol.
(b) Because the failure and complication rates from medical abortion increase with advancing gestational age, because the physical symptoms of medical abortion can be identical to the symptoms of ectopic pregnancy, and because abortion-inducing drugs do not treat ectopic pregnancies but rather are contraindicated in ectopic pregnancies, the physician giving, selling, dispensing, administering, or otherwise providing or prescribing the abortion-inducing drug shall first examine the woman and document in the woman's medical chart prior to giving, selling, dispensing, administering, or otherwise providing or prescribing the abortion-inducing drug the following information without limitation:
(1) Gestational age; and
(2) Intrauterine location of the pregnancy.
(c) Every pregnant woman to whom a physician gives, sells, dispenses, administers, or otherwise provides or prescribes any abortion-inducing drug shall b
Source: Arkansas Code — historical release 78 (November 6, 2020) · 20-16-1504
Stored review status: Historical 2020-11-06 source release; later amendments not reconciled; machine-extracted, not independently legally reviewed; source heading status: text_in_historical_source. The source passage cites 20-16-1504. This identifies an authority to review, not proof of applicability.
Arkansas Code — all titles (historical 2020) · legal_authorities
25-19-101. Title.
This chapter shall be known and cited as the “Freedom of Information Act of 1967”.
Source: Arkansas Code — historical release 78 (November 6, 2020) · 25-19-101
Stored review status: Historical 2020-11-06 source release; later amendments not reconciled; machine-extracted, not independently legally reviewed; source heading status: text_in_historical_source. The source passage cites 25-19-101. This identifies an authority to review, not proof of applicability.